Grown Rogue International (GRUSF) Shareholder's Equity Growth (1y) (2012 - 2026)
Grown Rogue International (GRUSF) Shareholder's Equity Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.44% |
| Dec 31, 2025 | 126.16% |
| Dec 31, 2024 | 55.16% |
| Oct 31, 2023 | 29.36% |
| Oct 31, 2022 | 25.55% |
| Oct 31, 2021 | 853.48% |
| Oct 31, 2020 | 33.81% |
| Oct 31, 2019 | -476.58% |
| Oct 31, 2018 | 18.09% |
| Aug 31, 2018 | -61.25% |
| Nov 30, 2017 | 46.22% |
| Aug 31, 2017 | 28.86% |
| Nov 30, 2016 | -30.88% |
| Aug 31, 2016 | 78.98% |
| May 31, 2016 | 219.39% |
| Feb 29, 2016 | -254.89% |
| Nov 30, 2015 | 76.74% |
| Aug 31, 2015 | -0.82% |
| Feb 28, 2015 | -6,495.51% |
| Aug 31, 2014 | -1,933.21% |